Type 2 diabetes control and complications in specialised diabetes care centres of six sub-Saharan African countries: The Diabcare Africa study

Diabetes Research and Clinical Practice

Volumn 95, Issue 1, 2012, Pages 30-36

  Sobngwi, Eugene ^a,b   Ndour Mbaye, Maimouna ^c   Boateng, Kofi A ^d   Ramaiya, Kaushik L ^e   Njenga, Eva W ^f   Diop, Said N ^c,g   Mbanya, Jean Claude ^b   Ohwovoriole, Augustine E ^h  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^c University Hospital Abass Ndao   (Senegal)

^d Medical Department   (Ghana)

^e Shree Hindu Mandal Hospital   (Tanzania)

^f AGA KHAN UNIVERSITY   (Kenya)

^g UNIVERSITÉ CHEIKH ANTA DIOP   (Senegal)

^h UNIVERSITY OF LAGOS   (Nigeria)

Author keywords

African origin populations; Complications(s); Disease Management; HbA1c; Type 2 diabetes

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL ANTIDIABETIC AGENT;

ADULT; AFRICA; ARTICLE; CATARACT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DESCRIPTIVE RESEARCH; DIABETES CONTROL; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE CONTROL; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEALTH CARE ACCESS; HEALTH CARE QUALITY; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT CARE; POPULATION DYNAMICS; SYSTOLIC BLOOD PRESSURE;

ADULT; AFRICA SOUTH OF THE SAHARA; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; MALE; MIDDLE AGED;

EID: 84355162878     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2011.10.018     Document Type: Article

References (18)

1. The Diabetes Atlas. Epidemiology and morbidity. Diabetes and impaired glucose tolerance. global burden: prevalence and projections, 2010 and 2030. 3rd ed. Brussels: International Diabetes Federation, 2007.
2. Boutayeb A., Boutayeb S. The burden of non communicable diseases in developing countries. Int J Equity Health 2005, 4:2.
3. Omar M.A., Seedat M.A., Motala A.A., Dyer R.B., Becker P. The prevalence of diabetes mellitus and impaired glucose tolerance in a group of urban South African blacks. S Afr Med J 1993, 83:641-643.
4. Aspray T.J., Mugusi F., Rashid S., Whiting D., Edwards R., Alberti K.G., Unwin N.C. Rural and urban differences in diabetes prevalence in Tanzania: the role of obesity, physical inactivity and urban living. Trans R Soc Trop Med Hyg 2000, 94:637-644.
5. Mbanya J.C., Ngogang J., Salah J.N., Balkau B. Prevalence of NIDDM and impaired glucose tolerance in a rural and an urban population in Cameroon. Diabetologia 1997, 40:824-829.
6. Sobngwi E., Mauvais-Jarvis F., Vexiau P., Mbanya J.C., Gautier J.F. Diabetes in Africans. Part 1: epidemiology and clinical specificities. Diabetes Metab 2001, 27:628-634.
7. Levitt N., Bradshaw D., Zwarenstein M.F., Bawa A.A., Maphumolo S. Audit of public sector primary diabetes care in Cape Town, South Africa: high prevalence of complications, uncontrolled hyperglycaemia, and hypertension. Diabetes Med 1997, 14:1073-1077.
8. Otieno C.F., Huho A.N., Omonge E.O., Amayo A.A., Njagi E. Type 2 diabetes mellitus: clinical and aetiologic types, therapy and quality of glycaemic control of ambulatory patients. East Afr Med J 2008, 85:24-29.
9. Gill G., Gebrekidan A., English P., Wile D., Tesfaye S. Diabetic complications and glycaemic control in remote North Africa. QJM 2008, 101:793-798.
10. Oga S.S., Lokrou A., Tebi A., Malan A.K., Papoz L., Kouadio L.P. Determinants of glycaemic control in type 2 diabetes African patients monitored by physicians from 1991 to 2004 in Cote d'Ivoire. Trans R Soc Trop Med Hyg 2010, 104:298-303.
11. Diabetes Mellitus in Europe: a problem at all ages in all countries. A model for prevention and self care. Acta Diabetol 1989, 27:181-183. WHO/IDF Saint Vincent Declaration Working Group.
12. A Model for Prevention and Self Care, Saint Vincent (Italy). A meeting organised by WHO and IDF in Europe, 10-12 October;1989.
13. Gaede P., Lund-Andersen H., Parving H.H., Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 2008, 358:580-591.
14. Rydén L., Standl E., Bartnik M., Van den Berghe G., Betteridge J., et al. Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC): European Association for the Study of Diabetes (EASD), Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J 2007, 28:88-136.
15. Kalk W.J., Joffe B.I. Differences in coronary heart disease prevalence and risk factors in African and White patients with type 2 diabetes. Diabetes Res Clin Pract 2007, 77:107-112.
16. Kengne A.P., Amoah A.G., Mbanya J.C. Cardiovascular complications of diabetes mellitus in sub-Saharan Africa. Circulation 2005, 112:3592-3601.
17. Mbanya J.C., Sobngwi E. Diabetes in Africa. Diabetes microvascular and macrovascular disease in Africa. J Cardiovasc Risk 2003, 10:97-102.
18. Higgins T., Stewart D., Boehr E. Challenges in HbA1c analysis and reporting: an interesting case illustrating the many pitfalls. Clin Biochem 2008, 41:1104-1106.